The 2010 event is currently in production. Check back often for updates, or opt in to receive email about Immunogenicity for Biotherapeutics.

Want to get involved with the 2010 conference? Contact the individuals below:

• Speaking Opportunities: Courtney Leonard, cleonard@iirusa.com
• Marketing & Media Partnerships: Jaclyn Grugett, jgrugett@iirusa.com
• Sponsorship & Exhibition Opportunities: Beth George, bgeorge@iirusa.com

Welcome to the 10^th Annual Immunogenicity for Biotherapeutics event delivering an excellent speaking faculty of senior level scientists and white paper authors to share new data and address your most pressing challenges.  Many of you are feeling increased pressure as FDA scrutiny of immunogenicity studies continues to climb.  While many strategies and practices have been developed and refined throughout the past few years, the industry still faces additional challenges in unifying guidelines.  Join us to hear regulatory updates and interact directly with white paper authors to help you discover solutions to implement in your lab.  Participate in our open discussions and help the industry continue to standardize immunogenicity practices.

Regulatory discussions, White Paper updates, Assay Development and Validation, New Technologies, Outsourcing, Ligand Binding vs. Cell Based Assays, and more - come prepared to have your most pressing questions addressed.  Our industry experts will present updated data, detailed case studies, facilitate discussions, and take time to answer your questions during the 10^th Annual Immunogenicity for Biotherapeutics Conference.

2008 Presentation now available.

Look Who's Coming in 2009: Acceleron Pharma Inc Genentech Inc Alexion Pharmacueticals Inc Genzyme Corporation Allergan Inc GlaxoSmithKline Biopharmaceuticals Alta Analytical Intertek Hematech Inc Amgen Kyowa Hakko Kirin California Amylin Pharmaceuticals MDS Pharma Services Astellas Pharma US Inc MedImmune Biogen Idec Merck & Company Inc BioMarin Pharmaceutical Inc Novartis BioMonitor AS PerkinElmer LAS Centocor Inc Prevalere Life Sciences Inc Charles River Laboratories Regeneron Pharmaceuticals Inc Cubist Pharmaceuticals Inc Roche Palo Alto Eli Lilly & Company Talecris Biotherapeutics Ferring Pharamceuticals A S Teva Pharmaceutical Industries Ltd ForteBio Inc UCB Pharma SA

New for 2009:   4 HOURS TO INTERACT Directly with White Paper Authors and Hear How to Integrate the Most Recent Industry Practices into your Lab 70% NEW SPEAKERS for 2009, Offering A Novel Perspective On Immunogenicity Issues including Rafael Ponce from Amgen and Robin Thorpe from National Institute for Biological Standards and Control 10 Case Studies on NEW ASSAY DEVELOPMENT AND VALIDATION Strategies 3 hours Focused on EMERGING TECHNOLOGIES AND TOOLS In Depth 3 Hour Statistical Analysis Workshop Addressing CUT-POINT DETERMINATION AND FOUR PARAMETER LOGISTIC MATHEMATICAL FUNCTION Network With 150+ INDUSTRY COLLEAGUES Half day dedicated to LIGAND BINDING VS. CELL BASED ASSAYS including Holly Smith from Eli Lilly & Company, Eric Wakshull from Genetech, Darshana Jani from Biogen IDEC and Edwin Golex from Amylin Pharmaceuticals 5 HOURS OF INTERACTIVE PANEL DISCUSSIONS Providing More Time To Get Your Most Pressing Questions Addressed 2008 Testimonials